Large-Scale Human Trials Launched for Experimental Bird Flu Vaccine
A landmark phase 3 trial for Moderna's mRNA-1018 bird flu vaccine has launched in the UK and US. Researchers aim to enroll 4,000 volunteers to test the jab's ability to protect against the evolving A(H5N1) strain, which has already impacted dairy cattle and marine mammals.